Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies

被引：3
|
作者：
Kevlicius, Lukas [1 ,2 ]
Cepulyte, Ruta [1 ]
Vasilevska, Dominika [2 ]
Griskevicius, Laimonas [1 ,2 ]
Zucenka, Andrius [1 ,2 ]
机构：
[1] Vilnius Univ Hosp Santaros Klinikos, Hematol Oncol & Transfus Med Ctr, Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, Inst Clin Med, Vilnius, Lithuania
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 06期
关键词：
D O I：
10.1038/s41409-022-01679-6
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1034 / 1037
页数：4
相关论文
共 50 条
  • [21] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [22] HIGH RATE OF MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS ACHIEVING COMPLETE REMISSION AFTER TREATMENT WITH VENETOCLAX-BASED REGIMENS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Piccini, M.
    Pilerci, S.
    Merlini, M.
    Scappini, B.
    Grieco, P.
    Bencini, S.
    Peruzzi, B.
    Caporale, R.
    Signori, L.
    Pancani, F.
    Vannucchi, A.
    Gianfaldoni, G.
    HAEMATOLOGICA, 2021, 106 (10) : 98 - 98
  • [23] Monocentric experience of venetoclax-based regimen in paediatric refractory and relapsed AML/MDS
    Cousson, Sophie
    Calvo, Charlotte
    Goldwirt, Lauriane
    Simonin, Mathieu
    Roupret-Serzec, Julie
    Dourthe, Marie Emilie
    Strullu, Marion
    Baruchel, Andre
    Dalle, Jean-Hugues
    Brethon, Benoit
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [24] Activity of combination trametinib/navitoclax in patients with RAS-mutated gynecologic (GYN) cancers in a Phase 1/2 study
    Liu, Joyce
    Xiong, Niya
    Lee, Elizabeth
    Do, Khanh
    Yeku, Oladapo
    Elsier, Catherine
    Barry, Suzanne
    Sullivan, Michaela
    Cheng, Su-Chun
    Brugge, Joan
    Chen, Helen
    Matulonis, Ursula
    Shapiro, Geoffrey
    Corcoran, Ryan
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S67 - S67
  • [25] Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma
    Basali, Diana
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Rosko, Nathaniel
    Reed, Janice
    Karam, Maryann
    Schlueter, Kristen
    Dysert, Hayley
    Kalaycio, Matt
    Valent, Jason
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) : 1136 - 1140
  • [26] Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma
    Basali, Diana
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Rosko, Nathaniel
    Reed, Janice
    Karam, Mary Ann
    Schlueter, Kristen
    Dysert, Hayley
    Faiman, Beth M.
    Hamilton, Kimberly
    Kalaycio, Matt
    Valent, Jason
    BLOOD, 2019, 134
  • [27] Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting
    Gong, Xubo
    Zhang, Yi
    He, Xin
    Moloudizargari, Milad
    Yu, Teng
    Wang, Lin
    Liu, Weiwei
    Jin, Lan
    Xu, Huiying
    Xu, Yang
    Tao, Zhihua
    Qian, Wenbin
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [28] Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting
    Xubo Gong
    Yi Zhang
    Xin He
    Milad Moloudizargari
    Teng Yu
    Lin Wang
    Weiwei Liu
    Lan Jin
    Huiying Xu
    Yang Xu
    Zhihua Tao
    Wenbin Qian
    Experimental Hematology & Oncology, 12
  • [29] Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting
    Xubo Gong
    Xin He
    Lin Wang
    Teng Yu
    Weiwei Liu
    Huiying Xu
    Lan Jin
    Xiang Li
    Bin Zhang
    Zhihua Tao
    Wenbin Qian
    Experimental Hematology & Oncology, 13
  • [30] Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting
    Gong, Xubo
    He, Xin
    Wang, Lin
    Yu, Teng
    Liu, Weiwei
    Xu, Huiying
    Jin, Lan
    Li, Xiang
    Zhang, Bin
    Tao, Zhihua
    Qian, Wenbin
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
12345